Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is Belinostat.
Product ID | 68152-108_8361737e-fcce-4a93-97ca-1220b1132979 |
NDC | 68152-108 |
Product Type | Human Prescription Drug |
Proprietary Name | Beleodaq |
Generic Name | Belinostat |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-07-21 |
Marketing Category | NDA / NDA |
Application Number | NDA206256 |
Labeler Name | Spectrum Pharmaceuticals, Inc. |
Substance Name | BELINOSTAT |
Active Ingredient Strength | 500 mg/10mL |
Pharm Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2014-07-21 |
Marketing End Date | 2022-11-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206256 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-07-21 |
Ingredient | Strength |
---|---|
BELINOSTAT | 500 mg/10mL |
SPL SET ID: | 84b2e16e-f0d1-4757-8da8-79dfa83aab79 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
68152-108 | Beleodaq | Belinostat |
69605-002 | Beleodaq | Belinostat |
72893-002 | Beleodaq | Belinostat |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BELEODAQ 86140026 4626277 Live/Registered |
ACROTECH BIOPHARMA LLC 2013-12-10 |